EyeGate Pharmaceuticals I...

NASDAQ: EYEG · Real-Time Price · USD
35.63
-0.08 (-0.22%)
At close: Aug 18, 2025, 3:06 PM
35.65
0.05%
After-hours: Aug 18, 2025, 04:04 PM EDT

EyeGate Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024
Period Ending Dec 31, 2024
Cash & Equivalents
3.79M
Short-Term Investments
23M
Long-Term Investments
n/a
Other Long-Term Assets
28.97K
Receivables
n/a
Inventory
n/a
Other Current Assets
2.91M
Total Current Assets
29.71M
Property-Plant & Equipment
62.4K
Goodwill & Intangibles
6.69M
Total Long-Term Assets
6.78M
Total Assets
36.48M
Account Payables
415.59K
Deferred Revenue
n/a
Short-Term Debt
23.36K
Other Current Liabilities
5.57M
Total Current Liabilities
6.01M
Long-Term Debt
33.81K
Other Long-Term Liabilities
4.19M
Total Long-Term Liabilities
4.72M
Total Liabilities
10.72M
Total Debt
57.17K
Common Stock
267.68K
Retained Earnings
-143.38M
Comprehensive Income
-282.16K
Shareholders Equity
25.76M
Total Investments
23M